Authorized purpose: Acts as a CADe second reader to detect and segment caries on periapical radiographs of permanent teeth in patients aged 12 years and older; clinicians review the contours and percentage analysis in context.
Clinical role
Second-reader aid for dental health professionals that uses machine learning to detect and segment caries on periapical radiographs, presenting overlays of segmented contours with each lesion's percentage overlap with dentine and enamel.
Images and patients
X-ray/Radiography · Dental/Maxillofacial
Key limitation
Keep in mind: The system is a second reader and does not replace complete dentist review or clinical judgment; family marketing and help content do not establish exact K243234 release behavior.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Acts as a CADe second reader to detect and segment caries on periapical radiographs of permanent teeth in patients aged 12 years and older; clinicians review the contours and percentage analysis in context.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Dental/Maxillofacial Input: Periapical radiographs of permanent teeth from patients 12 years of age or older, passed through the device's API to its machine learning modules for processing.
Who uses it?Intended users: Dental health professionals (dentists)
What does the software produce?Output: The AI model outputs a visual overlay of segmented contours highlighting detected carious lesions on the periapical radiograph. It provides detection of caries and a detailed analysis of the lesion's overlap with dentin and enamel, presented as a percentage. The clinician can hover over detected caries to view a segmentation analysis in the form of percentages.
What is its most important limitation?Key limitation: The system is a second reader and does not replace complete dentist review or clinical judgment; family marketing and help content do not establish exact K243234 release behavior.
Clinical takeaway. Clinical role: Acts as a CADe second reader to detect and segment caries on periapical radiographs of permanent teeth in patients aged 12 years and older; clinicians review the contours and percentage analysis in context.
Evidence takeaway. Evidence from the reviewed source record: Study type: Both. Cases: 1250. Reported sensitivity: 88%. Reader-study cases: 330. Readers: 21
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Acts as a CADe second reader to detect and segment caries on periapical radiographs of permanent teeth in patients aged 12 years and older; clinicians review the contours and percentage analysis in context.
Exact FDA submission
Checked 2026-09-06
Exact clinical-use normalization from the FDA packet; this text is also the locked corrections value.
Second-reader aid for dental health professionals that uses machine learning to detect and segment caries on periapical radiographs, presenting overlays of segmented contours with each lesion's percentage overlap with dentine and enamel.
Exact FDA submission
Checked 2026-11-14
Packet wording: "It is designed to aid dental health professionals to review periapical radiographs of permanent teeth in patients 12 years of age or older as a second reader." … "Second Opinion CS detects suspected carious lesions and presents them as an overlay of segmented contours. The software highlights detected caries with an overlay and provides a detailed analysis of the lesion’s overlap with dentine and enamel, presented as a percentage.". Read from the exact FDA decision document on 2026-11-14.
Periapical radiographs of permanent teeth from patients 12 years of age or older, passed through the device's API to its machine learning modules for processing.
Exact FDA submission
Checked 2026-11-14
Packet wording: "It is designed to aid dental health professionals to review periapical radiographs of permanent teeth in patients 12 years of age or older as a second reader." … "The API serves as a conduit for passing imagery and metadata between the user interface and the machine learning modules.". Read from the exact FDA decision document on 2026-11-14.
The AI model outputs a visual overlay of segmented contours highlighting detected carious lesions on the periapical radiograph. It provides detection of caries and a detailed analysis of the lesion's overlap with dentin and enamel, presented as a percentage. The clinician can hover over detected caries to view a segmentation analysis in the form of percentages.
Exact FDA submission
Checked 2026-09-01
Clinical output reported in the exact-submission ACR model card.
The system is a second reader and does not replace complete dentist review or clinical judgment; family marketing and help content do not establish exact K243234 release behavior.
Exact FDA submission
Checked 2026-09-06
Exact-product limitations and clinician-review boundary from the FDA packet.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Second Opinion® CS regulatory performance study summary
DesignStand-alone performance and reader study (ACR AI Central category)
PopulationAdult and Pediatric
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K243234
Samplen=1250
IndependenceIndependence not established
K243234
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
CMS states that Original Medicare does not pay for care, treatment, filling, removal or replacement of teeth or the structures directly supporting them (Social Security Act 1862(a)(12), 42 CFR 411.15(i)), except for inpatient hospital services and dental services that are integral to certain Medicare-covered medical services. This product's FDA-cleared use is analysis of dental radiographs, which falls in routine dental care, so no separate Medicare payment is expected outside those exceptions. Dental plan, CDT coding and private payer treatment of AI radiograph analysis were not reviewed, and no price or payment amount was established.
Original Medicare dental-service exclusion applies to routine dental care; dental plan and private payer treatment not reviewed
Medicare (Original Medicare, CMS) · United States
Service-level exclusion from the CMS dental coverage page; it does not address this product by name and does not establish coverage or payment by dental plans or other payers.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Periapical radiographs of permanent teeth from patients 12 years of age or older, passed through the device's API to its machine learning modules for processing.
Scope: Exact FDA submission. Packet wording: "It is designed to aid dental health professionals to review periapical radiographs of permanent teeth in patients 12 years of age or older as a second reader." … "The API serves as a conduit for passing imagery and metadata between the user interface and the machine learning modules.". Read from the exact FDA decision document on 2026-11-14.
Confirm scanner/model, protocol, series completeness and both software builds.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The exact FDA decision document was reviewed on 2026-11-14 and does not state the subject device's DICOM, PACS, RIS, or EHR interfaces. Confirm supported DICOM services and PACS, RIS, EHR, and interface versions with the vendor.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-11-14 ·
AI processing
Source context, not route validation: The exact FDA package describes Second Opinion CS as software that uses a cloud-based environment for processing, with an API passing imagery and metadata between a client user interface and machine learning modules. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "All three devices employ computer vision and machine learning to output detections, use cloud-based environments to conduct processing" … "The API serves as a conduit for passing imagery and metadata between the user interface and the machine learning modules.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: The AI model outputs a visual overlay of segmented contours highlighting detected carious lesions on the periapical radiograph. It provides detection of caries and a detailed analysis of the lesion's overlap with dentin and enamel, presented as a percentage. The clinician can hover over detected caries to view a segmentation analysis in the form of percentages.
Scope: Exact FDA submission. Clinical output reported in the exact-submission ACR model card.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: The AI model outputs a visual overlay of segmented contours highlighting detected carious lesions on the periapical radiograph. It provides detection of caries and a detailed analysis of the lesion's overlap with dentin and enamel, presented as a percentage. The clinician can hover over detected caries to view a segmentation analysis in the form of percentages.
Scope: Exact FDA submission. Clinical output reported in the exact-submission ACR model card.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes Second Opinion CS as software that uses a cloud-based environment for processing, with an API passing imagery and metadata between a client user interface and machine learning modules. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "All three devices employ computer vision and machine learning to output detections, use cloud-based environments to conduct processing" … "The API serves as a conduit for passing imagery and metadata between the user interface and the machine learning modules.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Pearl's data protection page states HIPAA-compliant logging of data access, TLS 1.2 in transit and AES-256 encryption at rest, with static code analysis and vulnerability scanning. Vendor-wide.
Vendor-wide
Checked 2026-10-25
Vendor statement, not an attestation; exact-release scope is not established.
The official Second Opinion page says the family product integrates directly with the imaging system and analyzes bitewing, periapical, and panoramic images automatically.
product family · checked 2026-09-06
Exact K243234 connector versions and current commercial terms require confirmation.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-07Last searched
27Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
Stored exact-submission candidate metadata had zero PubMed and ClinicalTrials.gov identifiers; this metadata screening is not a full paper or registry-record review. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, vendor product page, literature index, trial registry, payer policy, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-06 - Exact FDA submission
Official non-FDA product sources were reviewed for buyer and workflow context, but no exact-submission amount, currency, unit, term, or implementation fee was displayed. A vendor quote remains required.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Integration: Not publicly available - checked 2026-11-14 - Exact FDA submission
The exact FDA decision document was reviewed on 2026-11-14 and does not state the subject device's DICOM, PACS, RIS, or EHR interfaces. Confirm supported DICOM services and PACS, RIS, EHR, and interface versions with the vendor.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-08-13 - Exact FDA submission
Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Monitoring: Not verified - checked 2026-08-13 - Exact FDA submission
Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.
Authorized purpose: Aids dentists reviewing bitewing and periapical radiographs of permanent teeth by detecting/segmenting caries and periapical radiolucencies, identifying restorations and dental anatomy, and measuring mesial/distal bone levels; it does not replace dentist review.
Authorized purpose: Analyzes two-dimensional bitewing and periapical radiographs of permanent teeth in patients aged 15 and older to identify and localize caries, calculus, periapical radiolucency, root canal filling deficiency, discrepancy at an existing restoration margin, and bone loss; also supports alveolar bone-level measurement and restoration/dental-anatomy segmentation as an adjunct to dentist review.
Authorized purpose: Assists dentists in detecting caries, fillings/restorations, fixed prostheses, and implants on digital bitewing, periapical, and panoramic radiographs of permanent teeth in patients aged 15 years and older; final diagnoses and treatment plans remain the dentist's responsibility.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.